Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?

Myeloid growth factors, either granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF, are widely used to reduce the incidence and severity of chemotherapy-induced neutropenia by prophylactic or therapeutic administration. However, their activity in the novel therapeutic regimens,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossi, Paolo, Gurizzan, Cristina, Lorini, Luigi, di Mauro, Pierluigi, Sardini, Chiara, Merlano, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386202/
https://www.ncbi.nlm.nih.gov/pubmed/34429333
http://dx.doi.org/10.1136/jitc-2021-003154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386202/
https://www.ncbi.nlm.nih.gov/pubmed/34429333
http://dx.doi.org/10.1136/jitc-2021-003154

Ejemplares similares